298 related articles for article (PubMed ID: 30353124)
1. A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.
Saengwimol D; Rojanaporn D; Chaitankar V; Chittavanich P; Aroonroch R; Boontawon T; Thammachote W; Jinawath N; Hongeng S; Kaewkhaw R
Sci Rep; 2018 Oct; 8(1):15664. PubMed ID: 30353124
[TBL] [Abstract][Full Text] [Related]
2. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.
Srimongkol A; Laosillapacharoen N; Saengwimol D; Chaitankar V; Rojanaporn D; Thanomchard T; Borwornpinyo S; Hongeng S; Kaewkhaw R
J Exp Clin Cancer Res; 2023 Feb; 42(1):39. PubMed ID: 36726110
[TBL] [Abstract][Full Text] [Related]
3. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
4. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
5. Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration.
Winter U; Aschero R; Fuentes F; Buontempo F; Zugbi S; Sgroi M; Sampor C; Abramson DH; Carcaboso AM; Schaiquevich P
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832308
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
7. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
8. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
9. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
11. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin.
Liu H; Zhang Y; Zhang YY; Li YP; Hua ZQ; Zhang CJ; Wu KC; Yu F; Zhang Y; Su J; Jin ZB
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33628-33638. PubMed ID: 33318192
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds.
Goldsmith ZK; Coppess W; Irvine AS; Yuan K; Barsh SR; Ritter MK; McEwen MW; Flores-Otero J; Garcia-Vargas A; Martinez-Ferrer M; Brennan RC; Morales-Tirado VM; Wilson MW
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4486-4495. PubMed ID: 30193324
[TBL] [Abstract][Full Text] [Related]
15. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
16. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma.
Krishnakumar S; Mohan A; Kandalam M; Ramkumar HL; Venkatesan N; Das RR
Pediatr Blood Cancer; 2008 Feb; 50(2):402-6. PubMed ID: 17091485
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
18. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
Lawson BM; Saktanasate J; Say EA; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
[TBL] [Abstract][Full Text] [Related]
20. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]